Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
MOR

Overview Financials Analysis Smart Money

MorphoSys AG

MOR · NASDAQ

Analyze with AI

Filings1

Total reported value$19.3M

Manager	Shares	Value	Change
BlackRock Inc.	1M	$19.3M	-0.1%

SymbolMOR

Market Cap$2.9B

IPO Date2018-04-19

CEOArkadius Pichota

Employees464

SectorHealthcare

IndustryBiotechnology

CountryDE

ExchangeNASDAQ Global Select

ProPhase Labs, Inc.

PRPH

$0.897

+753.47%

Luminar Technologies, Inc.

LAZR

$0.6044

+174.73%

NovaBay Pharmaceuticals, Inc.

NBY

$5.30

+79.66%

Mint Incorporation Limited

MIMI

$0.4795

+75.45%

Autozi Internet Technology (Global) Ltd.

AZI

$2.50

+64.47%

Peers

Morphic Holding, Inc.

MORF · NASDAQ

$56.99

+0.04%

Chinook Therapeutics, Inc.

KDNY · NASDAQ

$40.39

+0.22%

Myovant Sciences Ltd.

MYOV · NYSE

$26.98

-0.04%

Provention Bio, Inc.

PRVB · NASDAQ

$24.98

+0.00%

SpringWorks Therapeutics, Inc.

SWTX · NASDAQ

$46.99

+0.02%

DICE Therapeutics, Inc.

DICE · NASDAQ

$47.55

+0.06%

Longboard Pharmaceuticals, Inc.

LBPH · NASDAQ

$59.98

0.00%

Calliditas Therapeutics AB (publ)

CALT · NASDAQ

$40.00

-0.10%

Fusion Pharmaceuticals Inc.

FUSN · NASDAQ

$21.55

+0.14%

BELLUS Health Inc.

BLU · NASDAQ

$14.75

+0.03%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.